000			02091 a2200577 4500
005			20250514012141.0
264		0	_c20011025
008			200110s 0 0 eng d
022			_a1524-4571
024	7		_a10.1161/hh2001.097691 _2doi
040			_aNLM _beng _cNLM
100	1		_aSilvestre, J S
245	0	0	_aProangiogenic effect of angiotensin-converting enzyme inhibition is mediated by the bradykinin B(2) receptor pathway. _h[electronic resource]
260			_bCirculation research _cOct 2001
300			_a678-83 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAngiotensin-Converting Enzyme Inhibitors _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAntihypertensive Agents _xpharmacology
650	0	4	_aBlood Flow Velocity _xdrug effects
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aCapillaries _xdrug effects
650	0	4	_aCell Count
650	0	4	_aCyclic GMP _xmetabolism
650	0	4	_aDisease Models, Animal
650	0	4	_aEndothelial Growth Factors _xmetabolism
650	0	4	_aFemoral Artery _xphysiopathology
650	0	4	_aHindlimb _xblood supply
650	0	4	_aIschemia _xphysiopathology
650	0	4	_aLymphokines _xmetabolism
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMice, Knockout
650	0	4	_aNeovascularization, Physiologic _xdrug effects
650	0	4	_aNitric Oxide _xmetabolism
650	0	4	_aNitric Oxide Synthase _xmetabolism
650	0	4	_aNitric Oxide Synthase Type II
650	0	4	_aNitric Oxide Synthase Type III
650	0	4	_aReceptor, Bradykinin B2
650	0	4	_aReceptors, Bradykinin _xdeficiency
650	0	4	_aSignal Transduction _xdrug effects
650	0	4	_aVascular Endothelial Growth Factor A
650	0	4	_aVascular Endothelial Growth Factors
700	1		_aBergaya, S
700	1		_aTamarat, R
700	1		_aDuriez, M
700	1		_aBoulanger, C M
700	1		_aLevy, B I
773	0		_tCirculation research _gvol. 89 _gno. 8 _gp. 678-83
856	4	0	_uhttps://doi.org/10.1161/hh2001.097691 _zAvailable from publisher's website
999			_c11517895 _d11517895